Search - tctmd.com

Displaying 21 - 37 of 37

Sort: Relevancy | Date

News Daily News

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

L.A. McKeown

June 01, 2022

News Conference News VIVA 2021

EMINENT: Better Patency With DES Over BMS for Fem-Pop Lesions

L.A. McKeown

October 12, 2021

News Daily News

Cardiac Deaths and Adverse Events After PCI Have Declined With Time

L.A. McKeown

October 05, 2021

News Daily News

Vascular Experts Say It’s Time to Let Paclitaxel Out of Regulatory Jail

L.A. McKeown

April 22, 2021

News Daily News

No Paclitaxel Death Signal in VA Data Out to 3 Years

L.A. McKeown

February 11, 2021

News Daily News

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

Michael O'Riordan

February 10, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2020

Shelley Wood

January 31, 2020

News Daily News

FDA Analysis Points to Higher Death Risk With Paclitaxel-Based Devices for PAD

L.A. McKeown

March 15, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for February 2019

Shelley Wood

March 01, 2019

News Daily News

No Excess Mortality Risk With Paclitaxel Stents in PAD, Second Medicare Analysis Finds

L.A. McKeown

March 01, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2018

Caitlin E. Cox

January 01, 2019

News Daily News

Use of DAPT Score Following PCI Validated in PRODIGY Study

Yael L. Maxwell

June 12, 2017

News Conference News EuroPCR 2016

Not Necessarily PERFECT, but Drug-Eluting Balloon Shows Promise for Erectile Dysfunction

Yael L. Maxwell

May 17, 2016

Presentation

Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

Presenter: Kenneth Rosenfield

June 25, 2015

News Daily News

La Neoaterosclerosis Intra Stent se asocia al Avance de la Placa en Arterias No Tratadas

June 16, 2015

News Daily News

In-Stent Neoatherosclerosis Tied to Plaque Progression in Untreated Arteries

June 16, 2015

News Daily News

Autopsy Study: About One-Third of DES Contain New Atherosclerosis

March 01, 2011

Advertisement

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

EMINENT: Better Patency With DES Over BMS for Fem-Pop Lesions

Cardiac Deaths and Adverse Events After PCI Have Declined With Time

Vascular Experts Say It’s Time to Let Paclitaxel Out of Regulatory Jail

No Paclitaxel Death Signal in VA Data Out to 3 Years

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

TCTMD’s Top 10 Most Popular Stories for January 2020

FDA Analysis Points to Higher Death Risk With Paclitaxel-Based Devices for PAD

TCTMD’s Top 10 Most Popular Stories for February 2019

No Excess Mortality Risk With Paclitaxel Stents in PAD, Second Medicare Analysis Finds

TCTMD’s Top 10 Most Popular Stories for December 2018

Use of DAPT Score Following PCI Validated in PRODIGY Study

Not Necessarily PERFECT, but Drug-Eluting Balloon Shows Promise for Erectile Dysfunction

Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

La Neoaterosclerosis Intra Stent se asocia al Avance de la Placa en Arterias No Tratadas

In-Stent Neoatherosclerosis Tied to Plaque Progression in Untreated Arteries

Autopsy Study: About One-Third of DES Contain New Atherosclerosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content